Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

PURPOSE: We report the 5-year analysis from the phase III Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients (DASISION) trial, evaluating long-term efficacy and safety outcomes of patients with chronic myeloid leukemia (CML) in chronic phase (CP) treated with dasati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Cortes, Jorge E., Saglio, Giuseppe, Kantarjian, Hagop M., Baccarani, Michele, Mayer, Jiří, Boqué, Concepción, Shah, Neil P., Chuah, Charles, Casanova, Luis, Bradley-Garelik, Brigid, Manos, George, Hochhaus, Andreas
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2016
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118045/
https://ncbi.nlm.nih.gov/pubmed/27217448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.64.8899
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky